Why the FDA should take more chances on riskier drugs
October 06, 2015 | An MIT study challenges the FDA to be more flexible in drug approvals, altering the odds based on the severity of the disease and availability of treatments. Pharmalot
October 06, 2015 | An MIT study challenges the FDA to be more flexible in drug approvals, altering the odds based on the severity of the disease and availability of treatments. Pharmalot
